Encorafenib: A Review in Metastatic Colorectal Cancer with a BRAF V600E Mutation

Al-Salama, ZT

Al-Salama, ZT (corresponding author), Springer Nat, Private Bag 65901, Auckland 0754, New Zealand.

DRUGS, 2021; 81 (7): 849

Abstract

Encorafenib (Braftovi(R)) is an oral small molecule BRAF inhibitor used in combination with cetuximab for the treatment of adult patients with metasta......

Full Text Link